Early Access — free while we kick the tires
EdgarHawk

Estepan Ian Michael

Chief Financial Officer

Officer
1 filing analyzed · 1 company · Latest 2024-09-03

Companies

Company Buys Sells Direction
Sarepta Therapeutics, Inc. SRPT 0 1 Net selling

Activity

September 2024
medium
Sell
5,985 shares
$822,100
Significance 4/10

CFO Estepan sold 5,985 shares of SRPT at $137.36 (Aug 30); retains 33,946 shares. Stock now -17.6% from 52-week high.

Estepan Ian Michael, Chief Financial Officer, executed a single sale of 5,985 shares for $822,099.60, reducing his holdings by 15.0%. The sale occurred at $137.36, a price that sits between the 52-week low of $67.31 and high of $163.85, and the stock has since declined to $135.10 (-17.6% from the 52-week high). The company reported strong revenue growth of +33.3% year-over-year and achieved a $6.5M net income in the latest quarter, though it was unprofitable over its most recent full fiscal year. With a P/E of 270.20 and $12.9B market cap, the valuation is elevated relative to earnings; the sale represents a routine disposition rather than a dramatic shift in the executive's ownership stake.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access